OVERVIEW

The Leukapheresis Market is expected to reach USD 32.94 million by 2026, growing at a CAGR of 7.36% during the forecast period. The rising demand for blood transfusions in patients with leukemia, lymphoma, and other blood disorders is said to contribute to the leukapheresis market growth. Blood donations have a short shelf life so regular supply of blood is required. Leukopaks are blood components procured from blood using leukapheresis. These blood components are required by patients who require such enriched blood cells. This demand for specific blood components will also contribute this market growth. With COVID-19 pandemic and possible resurge the hospitals are focussed on serving only the emergency cases and engage all of their resources in order to fight the coronavirus which has had an impact on the market growth.

TABLE OF CONTENT

• 1 Global Leukapheresis Market
  • 1.1 Study Objectives
  • 1.2 Market Definition
  • 1.3 Study Scope
    • 1.3.1 Markets Covered
    • 1.3.2 Geographic Scope

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Leukapheresis Market ? Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Leukapheresis Market ? Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Leukapheresis Market ? Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 Global Leukapheresis Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Leukapheresis Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Leukapheresis Market ? By Type (Market Size ? & million/billion)
  • 8.1 Leukapheresis Devices
  • 8.2 Leukapheresis Disposables

• 9 Global Leukapheresis Market - By Application
  • 9.1 Research Applications
  • 9.2 Therapeutic Applications

• 10 Global Leukapheresis Market - By End-User
  • 10.1 Blood Component Providers and Blood Centers
  • 10.2 Academic and Research Institutes
  • 10.3 Pharmaceutical and Biotechnology Companies
  • 10.4 Hospitals and Transfusion Centers

• 11 Global Leukapheresis Market ? By Geography (Market Size ? & million/billion)
  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 U.K
    • 11.3.2 Germany
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 South Korea
    • 11.4.5 Rest of APAC
  • 11.5 Rest of the World
    • 11.5.1 South America
    • 11.5.2 Middle East
    • 11.5.3 Africa

• 12 Global Leukapheresis Market ? Entropy
  • 12.1 New product launches
  • 12.2 M&A's, collaborations, JVs and partnerships

• 13 Global Leukapheresis Market Company Profile (Key Players)
  • 13.1 Market Share, Company Revenue, Products, M&A, Developments
  • 13.2 Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
  • 13.3 Fresenius Se & Co. KGaA
  • 13.4 Haemonetics Corporation
  • 13.5 Hemacare Corporation
  • 13.6 Key Biologics, LLC.
  • 13.7 Stemcell Technologies, Inc.
  • 13.8 Caltag Medsystems Limited
  • 13.9 Terumo BCT
  • 13.10 ALLCells, LLC.
  • 13.11 Stemexpress, LLC.
  • 13.12 Company 11 & more

• 14 Global Leukapheresis Market - Appendix
  • 14.1 Sources
  • 14.2 Abbreviations